Table 2 |
||||||
|
Comparison of the Aboriginality of STI† and BBV‡ notifications received in 2004 prior to and following data linkage by estimation method |
||||||
|
Aboriginal n (%) |
non-Aboriginal n (%) |
|||||
|
|
|
|||||
|
Disease |
Pre-linkage |
Sensitive |
Specific |
Pre-linkage |
Sensitive |
Specific |
|
|
||||||
|
Chlamydia |
1078 (25) |
1161 (27) |
1127 (26) |
1789 (41) |
2800 (65) |
2766 (64) |
|
Gonorrhoea |
1085 (76) |
1093 (76) |
1086 (76) |
307 (21) |
335 (23) |
328 (23) |
|
Syphilis |
137 (66) |
138 (67) |
137 (67) |
45 (22) |
67 (33) |
66 (32) |
|
Hepatitis B |
61 (14) |
64 (15) |
64 (15) |
317 (72) |
344 (79) |
344 (79) |
|
Hepatitis C |
134 (11) |
153 (13) |
138 (11) |
706 (58) |
1001 (82) |
986 (81) |
|
Total |
2496 (33) |
2610 (34) |
2553 (34) |
3164 (41) |
4547 (60) |
4490 (59) |
|
|
||||||
|
† Sexually Transmitted Infections (STI) excluding Donovanosis ‡ Blood borne virus (BBV) notifications, excluding HIV (Human Immunodeficiency virus) |
||||||
|
Mak and Watkins BMC Health Services Research 2008 8:118 doi:10.1186/1472-6963-8-118 |
||||||
